Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.
Richard M. Grimes, PhD
Advertisement
Articles by Richard M. Grimes, PhD
Advertisement
Latest Updated Articles
Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney DiseasePublished: January 17th 2025 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
3
How Medicaid Reforms Could Deepen State Coverage Gaps
4
NICU Nurses More Likely to Miss Tasks Due to Increased Workload
5
